Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation
Jan Storek(University of Washington), Harry C. Schouten, Marcie Riches(Medical College of Wisconsin), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Michael R. Verneris(NHS Blood and Transplant), Tom F.W. Wolfs(KU Leuven), Edmund K. Waller(Emory University), Margaret L. MacMillan(University of Minnesota Medical Center), Paul Szabolcs(Children's Hospital of Pittsburgh), Kirsten M. Williams(National Institutes of Health), Michael Boeckh(Fred Hutch Cancer Center), Hillard M. Lazarus(University Hospitals of Cleveland), Karen K. Ballen(University of Virginia Health System), Caroline A. Lindemans(University Medical Center Utrecht), Krishna V. Komanduri(University of Miami), Jo‐Anne H. Young(University of Minnesota System), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Baldeep Wirk(Boston University), Hisham Abdel‐Azim(University of Southern California), Daniel J. Weisdorf(University of Minnesota), Celalettin Üstün(Rush University Medical Center), Joseph Rosenthal(City Of Hope National Medical Center), Biju George(Westmead Hospital), Ami S. Bhatt(Stanford University), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bipin N. Savani(Vanderbilt University Medical Center), Min Chen(Medical College of Wisconsin), George Chen(The University of Texas MD Anderson Cancer Center), David A. Margolis(Medical College of Wisconsin), Joseph H. Antin(Harvard University), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Kwang Woo Ahn(Medical College of Wisconsin), Mary J. Laughlin(Cleveland Cord Blood Center), John R. Wingard(University of Florida Health)
Cited by 0
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k